Literature DB >> 22415154

Analysis of sentinel lymph node biopsy results in colon cancer in regard of the anthropometric features of the population and body composition assessment formulas.

Piotr Nowaczyk1, Dawid Murawa, Karol Połom, Magdalena Waszyk-Nowaczyk, Arkadiusz Spychała, Michał Michalak, Paweł Murawa.   

Abstract

PURPOSE: The aim of the study was to assess sentinel lymph node biopsy (SLNB) results in colon cancer (CC) regarding basic anthropometric features of the studied population and their derivatives calculated using mathematical formulas.
METHODS: One hundred three SLNBs in CC have been analysed. Various indicators were calculated for every patient using mathematical formulas: BMI, Roher's index, lean body weight, body fat percentage and body weight/ideal body weight for a given height ratios using the following formulas: Broca's, Broca's ideal weight, Broca-Brugsch, Lorenz's, Potton's, Devine's, Robinson's, Miller's and Hamwi. The results were compared with accuracy, sensitivity and false negative results percentage by means of ROC curves and the test for structure indicators (for determined cut-off points).
RESULTS: No statistically significant relationship between the results and patients' sex or age were found. ROC curve analysis did not reveal statistically significant relationships between the obtained results and indicators calculated on the basis of growth and weigh (all p > 0.05). The analyses of sensitivity and accuracy with determined cut-off point, in spite of differences amounting to 19 % (analysis of lean body weight/weight ratio), showed no statistical significance for any of the relationships (all p > 0.05).
CONCLUSIONS: No indicator with high diagnostic and prognostic value has been found. The problem of qualifying patients for SLNB in CC in regard of the anthropometric features of the population and body composition assessment formulas remains open and requires further analysis on larger populations.

Entities:  

Mesh:

Year:  2012        PMID: 22415154      PMCID: PMC3349851          DOI: 10.1007/s00423-012-0938-4

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  33 in total

1.  Combining radioisotopic and blue-dye technique does not improve the false-negative rate in sentinel lymph node mapping for colorectal cancer.

Authors:  Olivier Tiffet; David Kaczmarek; Marie Laure Chambonnière; Thomas Guillan; Sylviane Baccot; Nathalie Prévot; Sherban Bageacu; Eric Bourgeois; Elisabeth Cassagnau; Paul Antoine Lehur; Francis Dubois
Journal:  Dis Colon Rectum       Date:  2007-07       Impact factor: 4.585

2.  Use of sentinel node mapping for cancer of the colon: 'to map or not to map".

Authors:  Kristen A Thomas; Jonathan Lechner; Perry Shen; Gregory S Waters; Kim R Geisinger; Edward A Levine
Journal:  Am Surg       Date:  2006-07       Impact factor: 0.688

Review 3.  Sentinel lymph node mapping with GI cancer.

Authors:  Takashi Aikou; Yuko Kitagawa; Masaki Kitajima; Yoshikazu Uenosono; Anton J Bilchik; Steve R Martinez; Sukamal Saha
Journal:  Cancer Metastasis Rev       Date:  2006-06       Impact factor: 9.264

4.  Prospective multicenter trial of staging adequacy in colon cancer: preliminary results.

Authors:  Anton J Bilchik; Maggie DiNome; Sukamal Saha; Roderick R Turner; David Wiese; Martin McCarter; Dave S B Hoon; Donald L Morton
Journal:  Arch Surg       Date:  2006-06

5.  Laparoscopic lymphatic mapping and sentinel lymph node detection in colon cancer: technical aspects and preliminary results.

Authors:  Paolo Pietro Bianchi; Chiara Ceriani; Matteo Rottoli; Guido Torzilli; Massimo Roncalli; Antonino Spinelli; Marco Montorsi
Journal:  Surg Endosc       Date:  2007-02-07       Impact factor: 4.584

6.  A multicenter trial of sentinel lymph node mapping in colorectal cancer: prognostic implications for nodal staging and recurrence.

Authors:  Sukamal Saha; Rajesh Sehgal; Rajesh Seghal; Mehul Patel; Kiet Doan; Adrian Dan; Anton Bilchik; Thomas Beutler; David Wiese; Nader Bassily; Charles Yee
Journal:  Am J Surg       Date:  2006-03       Impact factor: 2.565

7.  Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.

Authors:  Amit Goyal; Robert G Newcombe; Alok Chhabra; Robert E Mansel
Journal:  Breast Cancer Res Treat       Date:  2006-03-16       Impact factor: 4.872

8.  Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

Authors:  Thierry André; Corrado Boni; Lamia Mounedji-Boudiaf; Matilde Navarro; Josep Tabernero; Tamas Hickish; Clare Topham; Marta Zaninelli; Philip Clingan; John Bridgewater; Isabelle Tabah-Fisch; Aimery de Gramont
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

9.  Sentinel lymph node biopsy in colon cancer: a prospective multicenter trial.

Authors:  Andreas E Bembenek; Robert Rosenberg; Elke Wagler; Stephan Gretschel; Andreas Sendler; Joerg-Ruediger Siewert; Jörg Nährig; Helmut Witzigmann; Johann Hauss; Christian Knorr; Arno Dimmler; Jörn Gröne; Heinz-Johannes Buhr; Jörg Haier; Hermann Herbst; Juergen Tepel; Bence Siphos; Axel Kleespies; Alfred Koenigsrainer; Nikolas H Stoecklein; Olaf Horstmann; Robert Grützmann; Andreas Imdahl; Daniel Svoboda; Christian Wittekind; Wolfgang Schneider; Klaus-Dieter Wernecke; Peter M Schlag
Journal:  Ann Surg       Date:  2007-06       Impact factor: 12.969

10.  Is sentinel lymph node mapping in colorectal cancer a future prognostic factor? A meta-analysis.

Authors:  Gaëtan Des Guetz; Bernard Uzzan; Patrick Nicolas; Michel Cucherat; Philippe de Mestier; Jean-François Morere; Jean-Luc Breau; Gérard Perret
Journal:  World J Surg       Date:  2007-06       Impact factor: 3.282

View more
  2 in total

1.  Extended lymphadenectomy in colon cancer is debatable.

Authors:  Jamie Murphy; Tonia Young-Fadok
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

2.  The impact of different algorithms for ideal body weight on screening for hydroxychloroquine retinopathy in women.

Authors:  David J Browning; Chong Lee; David Rotberg
Journal:  Clin Ophthalmol       Date:  2014-07-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.